162 related articles for article (PubMed ID: 18709987)
1. [Clinical usefulness of measurement of urine type IV collagen for detection of early phase of nephropathy in type 2 diabetic patients].
Inoue M; Oishi C; Shimajiri Y; Furuta M; Ueyama M; Sanke T
Rinsho Byori; 2008 Jul; 56(7):564-9. PubMed ID: 18709987
[TBL] [Abstract][Full Text] [Related]
2. [The significance of determination of urinary type IV collagen concentrations from a random urine collection in patients with non-insulin dependent diabetes mellitus].
Kotajima N; Fukumura Y; Obata K; Kobayashi I
Rinsho Byori; 1998 Mar; 46(3):277-82. PubMed ID: 9564768
[TBL] [Abstract][Full Text] [Related]
3. Urinary type IV collagen: a specific indicator of incipient diabetic nephropathy.
Tan Y; Yang Y; Zhang Z; Zhang X; Zhang Z; Liu Y
Chin Med J (Engl); 2002 Mar; 115(3):389-94. PubMed ID: 11940372
[TBL] [Abstract][Full Text] [Related]
4. Urinary type IV collagen levels in diabetes mellitus.
Sthaneshwar P; Chan SP
Malays J Pathol; 2010 Jun; 32(1):43-7. PubMed ID: 20614725
[TBL] [Abstract][Full Text] [Related]
5. [Revised criteria for the early diagnosis of diabetic nephropathy].
Inomat S; Haneda M; Moriya T; Katayama S; Iwamoto Y; Sakai H; Tomino Y; Matsuo S; Asano Y; Makino H;
Nihon Jinzo Gakkai Shi; 2005; 47(7):767-9. PubMed ID: 16296406
[TBL] [Abstract][Full Text] [Related]
6. [Changes in serum and urine ceruloplasmin concentrations in type 2 diabetes].
Qin LX; Zeng X; Huang G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):208-11. PubMed ID: 16145917
[TBL] [Abstract][Full Text] [Related]
7. Effect of tranilast in early-stage diabetic nephropathy.
Soma J; Sato K; Saito H; Tsuchiya Y
Nephrol Dial Transplant; 2006 Oct; 21(10):2795-9. PubMed ID: 16820373
[TBL] [Abstract][Full Text] [Related]
8. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of the aminopeptidase N, N-acetyl-beta-D-glucosaminidase and dipeptidylpeptidase IV in evaluating tubular dysfunction in patients with glomerulopathies.
Mitic B; Lazarevic G; Vlahovic P; Rajic M; Stefanovic V
Ren Fail; 2008; 30(9):896-903. PubMed ID: 18925530
[TBL] [Abstract][Full Text] [Related]
10. Urinary collagen IV and πGST: potential biomarkers for detecting localized kidney injury in diabetes--a pilot study.
Cawood TJ; Bashir M; Brady J; Murray B; Murray PT; O'Shea D
Am J Nephrol; 2010; 32(3):219-225. PubMed ID: 20664197
[TBL] [Abstract][Full Text] [Related]
11. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.
Doi T; Mima A; Matsubara T; Tominaga T; Arai H; Abe H
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S21-4. PubMed ID: 18842318
[TBL] [Abstract][Full Text] [Related]
12. [Urinary type IV collagen as a biological marker for diagnosis of diabetic nephropathies].
Araki S
Nihon Rinsho; 2005 Jun; 63 Suppl 6():362-6. PubMed ID: 15999735
[No Abstract] [Full Text] [Related]
13. [Current topics on urinary proteins: human albumin, protein 1, beta 2-microglobulin, and type IV collagen].
Itoh Y
Rinsho Byori; 2002 Jun; 50(6):555-60. PubMed ID: 12166072
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of 8-oxo-7, 8-dihydro-2'-deoxyguanosine as a predictor of the development of diabetic nephropathy.
Hinokio Y; Suzuki S; Hirai M; Suzuki C; Suzuki M; Toyota T
Diabetologia; 2002 Jun; 45(6):877-82. PubMed ID: 12107732
[TBL] [Abstract][Full Text] [Related]
15. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
Jain S; Rajput A; Kumar Y; Uppuluri N; Arvind AS; Tatu U
J Assoc Physicians India; 2005 Jun; 53():513-20. PubMed ID: 16121805
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of alpha-defensin (-1, -2 and -3) in type 1 diabetic patients with nephropathy.
Saraheimo M; Forsblom C; Pettersson-Fernholm K; Flyvbjerg A; Groop PH; Frystyk J;
Nephrol Dial Transplant; 2008 Mar; 23(3):914-8. PubMed ID: 18003664
[TBL] [Abstract][Full Text] [Related]
18. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
19. Does bacteriuria interfere with albuminuria measurements of patients with diabetes?
Kramer CK; Camargo J; Ricardo ED; Almeida FK; Canani LH; Gross JL; Azevedo MJ
Nephrol Dial Transplant; 2009 Apr; 24(4):1193-6. PubMed ID: 19015170
[TBL] [Abstract][Full Text] [Related]
20. Collagen type VIII expression in human diabetic nephropathy.
Gerth J; Cohen CD; Hopfer U; Lindenmeyer MT; Sommer M; Gröne HJ; Wolf G
Eur J Clin Invest; 2007 Oct; 37(10):767-73. PubMed ID: 17888087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
